1. Home
  2. LIVE vs RNTX Comparison

LIVE vs RNTX Comparison

Compare LIVE & RNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Live Ventures Incorporated

LIVE

Live Ventures Incorporated

N/A

Current Price

$20.16

Market Cap

30.3M

ML Signal

N/A

RNTX

Rein Therapeutics Inc.

HOLD

Current Price

$1.17

Market Cap

35.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LIVE
RNTX
Founded
1968
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
30.3M
35.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
LIVE
RNTX
Price
$20.16
$1.17
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$10.00
AVG Volume (30 Days)
7.7K
208.9K
Earning Date
02-05-2026
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
4.93
N/A
Revenue
$444,944,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$4.09
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.25
$1.02
52 Week High
$25.88
$3.50

Technical Indicators

Market Signals
Indicator
LIVE
RNTX
Relative Strength Index (RSI) 66.72 43.52
Support Level $19.00 $1.09
Resistance Level $21.00 $1.25
Average True Range (ATR) 1.15 0.09
MACD 0.16 0.00
Stochastic Oscillator 84.05 53.57

Price Performance

Historical Comparison
LIVE
RNTX

About LIVE Live Ventures Incorporated

Live Ventures Inc is a holding company for diversified businesses. It is focused on acquiring and operating profitable companies in various industries. The company operates in the business segments of Retail Entertainment which includes direct sales of entertainment and appliance products and services, Flooring Manufacturing, Steel Manufacturing, which includes the sale of steel plates, ground flat stock, and drill rods, and Corporate and Other. It derives key revenue from the Flooring Manufacturing segment which includes the manufacturing of carpets and rugs, yarn products, as well as a reseller of hard surface flooring products. Geographically the activities are carried out throughout the United States.

About RNTX Rein Therapeutics Inc.

Rein Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on developing therapies in orphan pulmonary and fibrosis indications, including two Phase 2-ready clinical assets. The company's product candidate includes LTI-03: a peptide for which company conducted a Phase 1b dose-ranging, placebo-controlled safety, tolerability, and pharmacodynamic biomarker activity trial in development for the treatment of Idiopathic Pulmonary Fibrosis; LTI-01: proenzyme that completed a Phase 2a dose-ranging, placebo-controlled trial and a Phase 1b safety, tolerability and proof of mechanism trial in loculated pleural effusion, or LPE, patients, an indication that has no approved drug treatment; and LTI-05 and others.

Share on Social Networks: